康恩贝股价微跌0.22% 子公司高血压新药获批上市

金融界2025-07-29

康恩贝7月28日股价报4.59元，较前一交易日下跌0.01元，跌幅0.22%。当日成交量为296784手，成交金额达1.37亿元。康恩贝属于中药板块，是一家集药品研发、生产、销售于一体的医药企业。公司产品涵盖中药制剂、化学原料药及制剂、生物制品等多个领域。7月28日公司公告显示，全资子公司杭州康恩贝制药有限公司获得国家药监局核准签发的培哚普利氨氯地平片（Ⅲ）《药品注册证书》。该药品用于治疗成人...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555705748?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-29 01:57","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2555705748","market":"sh","top_or_hot":-1,"title":"康恩贝股价微跌0.22% 子公司高血压新药获批上市","media":"金融界","content":"<div>\n<p>康恩贝7月28日股价报4.59元，较前一交易日下跌0.01元，跌幅0.22%。当日成交量为296784手，成交金额达1.37亿元。康恩贝属于中药板块，是一家集药品研发、生产、销售于一体的医药企业。公司产品涵盖中药制剂、化学原料药及制剂、生物制品等多个领域。7月28日公司公告显示，全资子公司杭州康恩贝制药有限公司获得国家药监局核准签发的培哚普利氨氯地平片（Ⅲ）《药品注册证书》。该药品用于治疗成人...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290205159723ab63&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康恩贝股价微跌0.22% 子公司高血压新药获批上市</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康恩贝股价微跌0.22% 子公司高血压新药获批上市\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-29 01:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290205159723ab63&s=b><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>康恩贝7月28日股价报4.59元，较前一交易日下跌0.01元，跌幅0.22%。当日成交量为296784手，成交金额达1.37亿元。康恩贝属于中药板块，是一家集药品研发、生产、销售于一体的医药企业。公司产品涵盖中药制剂、化学原料药及制剂、生物制品等多个领域。7月28日公司公告显示，全资子公司杭州康恩贝制药有限公司获得国家药监局核准签发的培哚普利氨氯地平片（Ⅲ）《药品注册证书》。该药品用于治疗成人...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290205159723ab63&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0060","symbol_name":"抗癌","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290205159723ab63&s=b","article_id":"2555705748","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290205159723ab63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2555705748","pubTimestamp":1753725446,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"康恩贝7月28日股价报4.59元，较前一交易日下跌0.01元，跌幅0.22%。当日成交量为296784手，成交金额达1.37亿元。康恩贝属于中药板块，是一家集药品研发、生产、销售于一体的医药企业。7月28日公司公告显示，全资子公司杭州康恩贝制药有限公司获得国家药监局核准签发的培哚普利氨氯地平片（Ⅲ）《药品注册证书》。该药品用于治疗成人高血压，2024年国内同类药品市场规模达4.36亿元。子公司已为该药品投入研发费用约1041万元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600572":"康恩贝","BK0060":"抗癌","BK0097":"医药电商","BK0239":"医药制造","BK0028":"国家队","BK0188":"融资融券","BK0012":"证金概念"},"translate_title":"Conba's stock price fell slightly by 0.22%, its subsidiary's new hypertension drug was approved for listing","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600572":1},"content_text":"康恩贝7月28日股价报4.59元，较前一交易日下跌0.01元，跌幅0.22%。当日成交量为296784手，成交金额达1.37亿元。康恩贝属于中药板块，是一家集药品研发、生产、销售于一体的医药企业。公司产品涵盖中药制剂、化学原料药及制剂、生物制品等多个领域。7月28日公司公告显示，全资子公司杭州康恩贝制药有限公司获得国家药监局核准签发的培哚普利氨氯地平片（Ⅲ）《药品注册证书》。该药品用于治疗成人高血压，2024年国内同类药品市场规模达4.36亿元。子公司已为该药品投入研发费用约1041万元。7月28日主力资金净流入361.06万元，占流通市值的0.03%。风险提示：药品销售存在不确定性，市场竞争风险需关注。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555705748","isCrawlerRequest":true}